About DexCom, Inc.
DexCom, Inc. (DXCM) has been publicly traded since 2005, making it a 21-year-old public company. It operates in the Medical Devices industry within the Healthcare sector. The company is headquartered in San Diego, United States and employs approximately 11,000 people. With a market capitalization of $25 billion, DXCM is a large established company.
Key Statistics
- Current Price
- $64.24
- Market Cap
- $25.05B
- 52-Week High
- $89.98
- 52-Week Low
- $54.11
- Sector
- Healthcare
- Industry
- Medical Devices
$1,000 Invested
Monthly Returns Heatmap
Annual Returns
| Year | Return | Start | End |
|---|---|---|---|
| 2026 | -3.21% | $66.37 | $64.24 |
| 2025 | -14.66% | $77.77 | $66.37 |
| 2024 | -37.33% | $124.09 | $77.77 |
| 2023 | +9.58% | $113.24 | $124.09 |
| 2022 | -15.64% | $134.24 | $113.24 |
| 2021 | +45.23% | $92.43 | $134.24 |
| 2020 | +69.02% | $54.69 | $92.43 |
| 2019 | +82.59% | $29.95 | $54.69 |
| 2018 | +108.75% | $14.35 | $29.95 |
| 2017 | -3.87% | $14.93 | $14.35 |
| 2016 | -27.11% | $20.48 | $14.93 |
| 2015 | +48.77% | $13.76 | $20.48 |
| 2014 | +55.46% | $8.85 | $13.76 |
| 2013 | +160.56% | $3.40 | $8.85 |
| 2012 | +45.97% | $2.33 | $3.40 |
| 2011 | -31.79% | $3.41 | $2.33 |
| 2010 | +69.14% | $2.02 | $3.41 |
| 2009 | +192.39% | $0.69 | $2.02 |
| 2008 | -68.74% | $2.21 | $0.69 |
| 2007 | -10.45% | $2.46 | $2.21 |
| 2006 | -33.91% | $3.73 | $2.46 |
Valuation
DXCM currently trades at a trailing P/E ratio of 30.7, which is considered high relative to the broader market. The forward P/E of 21.5 suggests analysts expect earnings to be lower in the coming year. The price-to-book ratio stands at 9.0. The price-to-sales ratio is 5.4.
Dividends
DexCom, Inc. does not currently pay a dividend, choosing to reinvest earnings back into the business for growth.
Risk & Volatility
DXCM has a beta of 1.53, indicating it is significantly more volatile than the overall market. The stock's 52-week range is $54.11 to $89.98, and it currently trades in the lower half of its 52-week range.
Analyst Ratings
Based on 26 analyst opinions, DXCM has a consensus "strong_buy" rating. The average price target of $86.12 suggests 34.1% upside from current levels.
Frequently Asked Questions
What does DexCom, Inc. do? ▼
DexCom, Inc. is a Medical Devices company operating in the Healthcare sector. The company is headquartered in San Diego, United States.
What sector is DXCM in? ▼
DXCM operates in the Healthcare sector, specifically in the Medical Devices industry.
When did DXCM go public? ▼
DexCom, Inc. went public in 2005, making it a 21-year-old public company as of 2026.
How much would $1,000 invested in DXCM 5 years ago be worth today? ▼
A $1,000 investment in DXCM five years ago would be worth approximately $708 today, representing a -29.2% return.
Does DXCM pay dividends? ▼
No, DexCom, Inc. does not currently pay a dividend. The company reinvests its earnings into growth.
What is DXCM's market cap? ▼
DexCom, Inc. has a market capitalization of $25 billion, classifying it as a large-cap company.
What is DXCM's P/E ratio? ▼
DXCM has a trailing P/E ratio of 30.7 and a forward P/E of 21.5, which measures how much investors are paying per dollar of earnings.
Is DXCM a buy, hold, or sell? ▼
Based on 26 opinions, DXCM has a consensus "strong_buy" rating. The average price target is $86.12.
Last updated: 3/14/2026